Fraxiparine Forte

Fraxiparin forte is a direct anticoagulant, low molecular weight heparin containing sodium heparin. In pharmacology, it is used as an anticoagulant in the treatment of acute coronary syndrome, thrombophlebitis, treatment of diseases of the musculoskeletal system, etc. It is a direct coagulation, the mechanism of action of which is the ability to bind thrombin factor Xlla before it activates fibrinogen. After the conversion of inactive factor Xa to active factor Xll, thrombin is formed in a tissue-specific manner. Heparin is a component of normal blood clotting and plays a key role in hemostasis, so over the past 30 years, a long-term transformation of the molecular structure of heparin has been carried out, capable of inhibiting its blood clotting, especially when it is needed. The blood is clotted and there is no blood. When released into injectable solutions, the fraction molecules are a group of 4 heparins that have an antithrombotic effect known as sodium heparin and are known in dentistry and pharmacological research. Absorption of the drug into the blood occurs when injected into the muscles. Those. For faster absorption of fraxiparine, muscles are used. Intramuscular administration allows complete absorption of the drug one day after injection through the thigh, lower leg, shoulder, abdomen or buttock, depending on the location of the lesion. When taken orally, the drug is absorbed within 8-1

Fraxiparine forte is a drug belonging to the group of direct-acting anticoagulants. It was developed by the French pharmaceutical concern Sanofi-Winthrop for the treatment and prevention of thromboembolic complications. It is available in various forms for